Immunoprofiling of leukemic stem cells CD34+/CD38−/CD123+ delineate FLT3/ITD-positive clones
Abstract Background Acute myeloid leukemia (AML) is a heterogeneous clonal disorder presenting with accumulation of proliferating undifferentiated blasts. Xenograft transplantation studies have demonstrated a rare population of leukemia-initiating cells called leukemic stem cells (LSCs) capable of p...
Main Authors: | Adhra Al-Mawali, David Gillis, Ian Lewis |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2016-07-01
|
Series: | Journal of Hematology & Oncology |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13045-016-0292-z |
Similar Items
-
Study of leukemic stem cell population (CD34+/CD38-) and WT1 protein expression in human leukemic cell lines
by: Pawaret Panyajai, et al.
Published: (2018-01-01) -
CD45dimCD34+CD38−CD133+ cells have the potential as leukemic stem cells in acute myeloid leukemia
by: Sook-Kyoung Heo, et al.
Published: (2020-04-01) -
SIRPα-αCD123 fusion antibodies targeting CD123 in conjunction with CD47 blockade enhance the clearance of AML-initiating cells
by: Siret Tahk, et al.
Published: (2021-09-01) -
FLT3/ITD associated with an immature immunophenotype in PML-RARα leukemia
by: Mariko Takenokuchi, et al.
Published: (2012-10-01) -
CD123-Targeted Nano-Curcumin Molecule Enhances Cytotoxic Efficacy in Leukemic Stem Cells
by: Wariya Nirachonkul, et al.
Published: (2021-11-01)